Cargando…
Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
The current study evaluated the differential expression detected in the proteomic profiles of low risk- and high risk- ALL pediatric patients to characterize candidate biomarkers related to diagnosis, prognosis and patient targeted therapy. Bone marrow and peripheral blood plasma and cell lysates sa...
Autores principales: | Braoudaki, Maria, Lambrou, George I, Vougas, Konstantinos, Karamolegou, Kalliopi, Tsangaris, George T, Tzortzatou-Stathopoulou, Fotini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717072/ https://www.ncbi.nlm.nih.gov/pubmed/23849470 http://dx.doi.org/10.1186/1756-8722-6-52 |
Ejemplares similares
-
The frequency of NPM1 mutations in childhood acute myeloid leukemia
por: Braoudaki, Maria, et al.
Publicado: (2010) -
Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach
por: Sifakis, Emmanouil G, et al.
Publicado: (2011) -
Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms
por: Braoudaki, Maria, et al.
Publicado: (2014) -
MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown
por: Braoudaki, Maria, et al.
Publicado: (2015) -
Effects of an Early Experience of Reward through Maternal Contact or its Denial on Laterality of Protein Expression in the Developing Rat Hippocampus
por: Raftogianni, Androniki, et al.
Publicado: (2012)